Egestad Helen, Nieder Carsten
Faculty of Health Sciences, Department of Health and Care Sciences, UiT, The Arctic University of Norway, 9037, Tromsø, Norway,
Support Care Cancer. 2015 Apr;23(4):1081-90. doi: 10.1007/s00520-014-2463-1. Epub 2014 Oct 4.
The aim of this study was to evaluate health-related quality of life (HRQOL) in patients with different body mass indices (BMI, <25 vs ≥25) undergoing radiation treatment for head and neck cancer.
HRQOL was examined by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and the EORTC QLQ-H&N35, in the beginning and in the end of radiation treatment in 60 patients treated at University Hospital in Northern Norway. Information about nutritional status with weight loss, hemoglobin level (Hb), serum albumin, and a study-specific questionnaire also was filled out in the beginning and in the end of treatment. The patients' general condition, skin, and mucous membranes (CTCAE v.3.0) (grades 1 to 5 with unique clinical descriptions) were documented four times during radiation treatment. Changes in HRQOL were calculated and compared by paired sample t test. Multiple regression analyses were used to examine correlations between baseline BMI and changes in HRQOL, CTCAE v.3.0 toxicity, nutritional status, and information that radiotherapists provided to patients.
Patients with BMI ≥ 25 had less mucosal changes after 2 weeks of radiation treatment than patients with BMI < 25 (p = 0.010). Differences regarding feeding tube use (p = 0.037) and intake of nutritional supplements before radiation treatment (p = 0.001) were also seen. Patients with overweight had more dyspnea (p = 0.033) before treatment and more problems with dry mouth (p = 0.042) after treatment. During treatment, patients with BMI ≥ 25 had more problems with opening mouth (p = 0.034) than patients with BMI < 25 and more changes in sexuality (p = 0.019). Patients with BMI ≥ 25 received less information about food and drink (p = 0.011) in the radiation treatment period than normal weight patients.
BMI influences HRQOL and toxicity. Additional longitudinal studies should examine whether or not overweight patients persistently experience more problems with dry mouth and opening their mouth. Regardless of BMI, all patients should be informed about nutritional recommendations during treatment.
本研究旨在评估接受头颈癌放射治疗的不同体重指数(BMI,<25 与≥25)患者的健康相关生活质量(HRQOL)。
在挪威北部大学医院接受治疗的60例患者中,于放射治疗开始时和结束时,采用欧洲癌症研究与治疗组织(EORTC)QLQ-C30和EORTC QLQ-H&N35问卷对HRQOL进行评估。在治疗开始时和结束时,还填写了有关体重减轻、血红蛋白水平(Hb)、血清白蛋白的营养状况信息以及一份特定研究问卷。在放射治疗期间,对患者的一般状况、皮肤和黏膜(CTCAE v.3.0)(1至5级并伴有独特的临床描述)进行了4次记录。通过配对样本t检验计算并比较HRQOL的变化。采用多元回归分析来检验基线BMI与HRQOL变化、CTCAE v.3.0毒性、营养状况以及放射治疗师向患者提供的信息之间的相关性。
BMI≥25的患者在放射治疗2周后黏膜变化少于BMI<25的患者(p = 0.010)。在放射治疗前使用饲管情况(p = 0.037)和营养补充剂摄入情况(p = 0.001)方面也存在差异。超重患者在治疗前呼吸困难更多(p = 0.033),治疗后口干问题更多(p = 0.042)。在治疗期间,BMI≥25的患者比BMI<25的患者张口困难问题更多(p = 0.034),性功能变化更多(p = 0.019)。与正常体重患者相比,BMI≥25的患者在放射治疗期间获得的有关饮食的信息更少(p = 0.011)。
BMI影响HRQOL和毒性。更多的纵向研究应考察超重患者是否持续存在更多的口干和张口问题。无论BMI如何,所有患者在治疗期间均应被告知营养建议。